相关实验视频

Updated: Jan 11, 2026

Microfluidics in Assessing Platelet Function

Microfluidics in Assessing Platelet Function

Published on: November 8, 2024

透析患者的皮肤冠状动脉干预后血小板聚合和临床事件之间的关系 - 一个吊分析子研究

Daiki Yoshiura¹, Masanori Taniwaki¹, Yoshihisa Nakagawa²

¹Division of Cardiology, Mitsui Memorial Hospital Tokyo Japan.

Circulation reports

|November 11, 2025

概括

高血小板反应性 (HPR) 没有增加经皮冠状动脉干预 (PCI) 后血液透析患者发生重大心脏和脑血管不良事件 (MACCE) 或出血的风险. 需要进一步的研究来了解透析患者的这些结果.

科学领域:

心脏病学心脏病学
腎臟病學 (nephrology) 是一種醫學專業.
药理学药理学是指药理学的学科.

背景情况:

接受血液透析的末期病患者 (HD) 面临经皮冠状动脉干预 (PCI) 后缺血和出血并发症的风险增加.
高血小板反应率 (HPR) 对接受PCI的透析患者临床结果的具体影响仍然不完全理解.
这项研究调查了HPR与高危人群中心血管和出血不良事件之间的关联.

研究的目的:

检查透析患者高血小板反应率 (HPR) 和主要心脏和脑血管不良事件 (MACCE) 之间的关系.
评估在接受PCI的透析患者中HPR和重大出血事件之间的关联.
为了比较透析患者与没有HPR的结果.

主要方法:

对PENDULUM注册表数据进行了后期分析.
患者被分为HPR (P2Y12反应单元[PRU]>208) 和非HPR (PRU ≤208) 组.
在357名透析患者和5550名非透析患者中,PCI后长达30个月的临床事件被跟踪.

主要成果:

与非透析患者相比,透析患者的MACCE和严重出血明显增加.
在非透析患者中,HPR与MACCE的增加有关,但没有出血.
相比之下,HPR在透析患者队列中与MACCE或严重出血没有显著关联.

结论:

在接受血液透析的患者中,高血小板反应率 (HPR) 没有发现与MACCE或严重出血的风险增加有关.
这些发现表明,超出HPR的因素可能会导致PCI后透析患者的不良事件.
需要进一步的研究,以阐明影响心血管和出血风险的因素的复杂相互作用.

关键词:

透析是通过透析进行的.双重抗血小板疗法双重抗血小板疗法高血小板反应性高血小板反应性通过皮肤进行冠状动脉干预.

更多相关视频

Turbidimetry on Human Washed Platelets: The Effect of the Pannexin1-inhibitor Brilliant Blue FCF on Collagen-induced Aggregation

Turbidimetry on Human Washed Platelets: The Effect of the Pannexin1-inhibitor Brilliant Blue FCF on Collagen-induced Aggregation

Published on: April 6, 2017

Analyzing Platelet Subpopulations by Multi-color Flow Cytometry

Analyzing Platelet Subpopulations by Multi-color Flow Cytometry

Published on: June 10, 2025

相关概念视频

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...

Formation of the Platelet Plug

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...